CClinicalTrials.gg
CompletedNCT04691934Updated Dec 31, 2020

Obstetric Anesthesia Experiences in COVID-19 Positive Patients

An observational study in Covid19 and Obstetric Anesthesia, sponsored by Turkiye Yuksek Ihtisas Education and Research Hospital. Completed at 1 site in Turkey. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-12-31.

Sponsored by Turkiye Yuksek Ihtisas Education and Research Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
61
Ages
18 Years and older
Sex
Female
01

Study summary

At the end of 2019, a new coronavirus named COVID-19 (SARS-CoV-2), one of the lower respiratory tract samples was detected in China. The World Health Organization (WHO) declared it a global epidemic on March 11, 2020, due to the emergence of COVID-19 cases in 113 countries other than China, where the first epidemic occurred, and the spread and severity of the virus. Pregnancy increases susceptibility to respiratory complications of viral diseases.

This study aimed to retrospectively evaluate the demographic data of COVID-19 patients undergoing cesarean section, our anesthesia practices, complications, and condition of neonates, and to summarize up-to-date information on COVID-19 in obstetric anesthesia.

Read the detailed description

Our study was a single-center, retrospective, and observational trial and carried out with the principles of the Declaration of Helsinki. All patient demographics and information about anesthesia were analyzed retrospectively from the patient files.

All patients were operated in negative pressure operating theatres reserved for them. The whole team was equipped with Level 3 personal protective equipment (PPE) (liquid-proof apron, N-95 mask, goggles, visor, overshoes). Anesthesia was administered by 2 healthcare professionals from the anesthesia team, including an experienced anesthesiologist and an assistant anesthesia technician. A third person was kept ready outside to help in case of need.

02

Conditions studied

  • Covid19
  • Obstetric Anesthesia

Browse trials for

Keywords

  • COVID-19
  • Anesthesia
  • Cesarean Section
  • Pneumonia
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 61 is below the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Turkiye Yuksek Ihtisas Education and Research Hospital is the lead sponsor of 9 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients who underwent cesarean section and had positive PCR nasopharyngeal swabs for COVID-19

Inclusion criteria

  • Patients who underwent cesarean section
  • Patients who had positive PCR nasopharyngeal swabs for COVID-19

Exclusion criteria

Exclusion Criteria:

  • Patients who tested negative and were clinically suspicious
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
61 participants (actual)
Patient registry
No

Interventions

  • ProcedureAnesthesia management

    Patients who underwent cesarean section and had positive PCR nasopharyngeal swabs for COVID-19 were included in the study. Patients who tested negative and were clinically suspicious were excluded from the study. PCR test was not performed on all elective and emergency pregnant women to be taken for cesarean section in our hospital. It was only applied to patients with symptoms or patients who were suspected. All patient demographics and information about anesthesia were analyzed retrospectively from the patient files.

06

What researchers measure

Primary outcomes

  1. obstetric anesthesia practices

    the type of anesthesia was investigated

    Time frame: until 30 minutes after arrival in the operating room

Secondary outcomes

  1. anesthesia complications

    hypotension, nausea, vomiting, allergies

    Time frame: up to 1 hour after anesthesia

07

Study locations

1 site
  • University of Health Sciences Turkey, Bursa Yuksek Ihtisas Training and Research Hospital
    Bursa, Yıldırım 16290, Turkey
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 31, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04691934
Lead sponsor
Turkiye Yuksek Ihtisas Education and Research Hospital
Responsible party
Derya Karasu, MD (Assoc Prof., Turkiye Yuksek Ihtisas Education and Research Hospital) — Principal investigator
First posted
Dec 31, 2020
Start date
Mar 11, 2020
Primary completion
Dec 25, 2020
Completion
Dec 25, 2020
Last update
Dec 31, 2020

Study contacts

Derya Karasu
principal investigator · BursaYuksek Ihtisas Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion